Clinical Advisor Director Nikki Kean sat down with Dr Leners at the American Association of Nurse Practitioners (AANP) annual ...
A presentation at AANP 2026 highlights the role of primary care nurse practitioners in screening older patients for geriatric ...
BC, presented ways in which artificial intelligence (AI) can be part of the solution to widespread burnout among NPs. Dr ...
Opioid prescribing has generally decreased between 2010 and 2024, with variations based on duration of use and prescriber specialty, according to research results published in JAM ...
Despite the end of nationwide shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the market for compounded GLP-1 RA alternatives remains strong, and some of these products are from ...
The transition from accelerated to traditional approval is backed by robust 24-month eGFR data from the phase 3 APPLAUSE-IgAN trial.
The CDC stated that it is "committed to working with partners to prioritize patient safety and invest in innovative strategies to further reduce health care-associated infections and protect the ...
Hypoactive sexual desire disorder is a common, underrecognized condition in women that arises from neurologic, hormonal, and ...
Researchers analyzed the impact of disease control and cumulative glucocorticoid exposure on muscle mass preservation in rheumatoid arthritis.
Credit: Getty Images In the health care industry, providing false information on a job application regarding a felony conviction or guilty plea constitutes grounds for termination, regardless of ...
Many nurse practitioners operating under restricted practice authority experience little to no face-to-face interaction or ...
Topline data from the phase 3 E-BEOND and C-BEOND trials show a significant reduction in monthly migraine days at 24 weeks, demonstrating efficacy across the full migraine spectrum.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results